SCHEMBL840090

SCHEMBL840090

CCCN(CCC)C(=O)c1ccc(C(N)=O)cn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NNMT P40261 4/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MLYCD O95822 2/20 0.44
TP53 P04637 1/20 0.44
HCAR3 P49019 2/20 0.43
EPHX2 P34913 1/20 0.43
EGFR P00533 1/20 0.42
ERBB2 P04626 1/20 0.42
HPGD P15428 1/20 0.40
PARP10 Q53GL7 1/20 0.39
KDM4E B2RXH2 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
P4HA1 P13674 1/20 0.39
MIF P14174 1/20 0.39
P4HTM Q9NXG6 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC2 Q92769 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL840867 0.86 HCAR3 (0.59) SMN1; SMN2MLYCDTP53HCAR3EGFR
SCHEMBL22182995 0.79 NNMT (0.52) NNMTSMN1; SMN2HPGDKDM4EL3MBTL1
SCHEMBL28278838 0.79 MLYCD (0.62) SMN1; SMN2MLYCDTP53EGFRERBB2
SCHEMBL3807628 0.78 ALDH1A1 (0.49) MLYCDTP53EGFRERBB2HPGD
SCHEMBL1812657 0.75 CXCR4 (0.43) NNMTSMN1; SMN2KDM4EL3MBTL1P4HA1
SCHEMBL7656690 0.74 P4HTM (0.43) MLYCDHCAR3KDM4EL3MBTL1P4HA1
SCHEMBL978974 0.74 NNMT (0.63) NNMTSMN1; SMN2KDM4EL3MBTL1P4HA1
SCHEMBL14852700 0.74 HCAR3 (0.75) NNMTSMN1; SMN2HCAR3EPHX2PARP10
SCHEMBL7081537 0.73 NNMT (0.57) NNMTSMN1; SMN2KDM4EL3MBTL1P4HA1
SCHEMBL5429491 0.73 MLYCD (0.51) MLYCDTP53HCAR3EGFRERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143408-B2 N-(8-heteroaryltetrahydronaphtalene-2yl) or N-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain ASTRAZENECA AB (SE) 2012-03-27 US claimed
EP-2158198-A2 NOVEL N- (8HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N- (5- HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN AstraZeneca AB (SE) 2010-03-03 EP claimed
WO-2008130320-A2 NOVEL N- (8-HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N- (5- HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN ASTRAZENECA AB (SE) 2008-10-30 WO claimed
US-8143408-B2 N-(8-heteroaryltetrahydronaphtalene-2yl) or N-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain ASTRAZENECA AB (SE) 2012-03-27 US disclosed
EP-2158198-A2 NOVEL N- (8HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N- (5- HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN AstraZeneca AB (SE) 2010-03-03 EP disclosed
WO-2008130320-A2 NOVEL N- (8-HETEROARYLTETRAHYDRONAPHTALENE-2YL) OR N- (5- HETEROARYLCHROMANE-3-YL) CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF PAIN ASTRAZENECA AB (SE) 2008-10-30 WO disclosed